These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6759943)

  • 1. Immunosuppression by avirulent, pseudohyphal forms of Cryptococcus neoformans.
    Blackstock R; Hall NK
    Mycopathologia; 1982 Nov; 80(2):95-9. PubMed ID: 6759943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Infect Immun; 1979 May; 24(2):449-53. PubMed ID: 378854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.
    Moser SA; Lyon FL; Domer JE; Williams JE
    Infect Immun; 1982 Feb; 35(2):685-96. PubMed ID: 7035372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
    Miller GP; Puck J
    J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.
    Mody CH; Lipscomb MF; Street NE; Toews GB
    J Immunol; 1990 Feb; 144(4):1472-7. PubMed ID: 1968080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions of immune lymphocytes and Cryptococcus neoformans.
    Fung PY; Murphy JW
    Infect Immun; 1982 Jun; 36(3):1128-38. PubMed ID: 7047393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell response during infection with the MAT a and MAT alpha mating types of Cryptococcus neoformans.
    Rodrigues AR; Heise N; Previato JO; Mendonça-Previato L; Peçanha LM
    Microbes Infect; 2005 Jan; 7(1):118-25. PubMed ID: 15716070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.
    Kozel TR; Cazin J
    Mycopathol Mycol Appl; 1974 Oct; 54(1):21-30. PubMed ID: 4139653
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
    Nabavi N; Murphy JW
    Infect Immun; 1986 Feb; 51(2):556-62. PubMed ID: 3510982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness.
    Kozel TR; Gulley WF; Cazin J
    Infect Immun; 1977 Dec; 18(3):701-7. PubMed ID: 338489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro responses to Cryptococcus neoformans.
    Hoy JF; Lewis DE; Miller GG
    J Infect Dis; 1988 Nov; 158(5):1071-8. PubMed ID: 3053921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific immunosuppression by Cryptococcus neoformans infection.
    Blackstock R; Hall NK
    Mycopathologia; 1984 Apr; 86(1):35-43. PubMed ID: 6234468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cellular resistance of beige mice against Cryptococcus neoformans.
    Hidore MR; Murphy JW
    J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice.
    Reiss F; Alture-Werber E
    Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.
    Rivera J; Zaragoza O; Casadevall A
    Infect Immun; 2005 Feb; 73(2):1141-50. PubMed ID: 15664957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Cryptococcus neoformans infection in the absence of CD4+ T cells.
    Aguirre K; Crowe J; Haas A; Smith J
    Med Mycol; 2004 Feb; 42(1):15-25. PubMed ID: 14982110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohyphal forms of Cryptococcus neoformans: decreased survival in vivo.
    Neilson JB; Fromtling RA; Bulmer GS
    Mycopathologia; 1981 Jan; 73(1):57-9. PubMed ID: 7012632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of specific antibody to Cryptococcus neoformans by hybridomas in vitro.
    Hall NK; Blackstock R
    Sabouraudia; 1981 Jun; 19(2):157-60. PubMed ID: 7020113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.